Singular Genomics Systems... (OMIC)
NASDAQ: OMIC
· Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM
Singular Genomics Systems Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.8M | -21.25M | -25.02M | -23.25M | -22.36M | -25.58M | -23.63M | -21.1M | -23.79M | -23.98M | -22.01M | -19.76M | -17.61M | -37.48M | -23.92M |
Depreciation & Amortization | 1.69M | 1.78M | 1.72M | 1.65M | 1.87M | 1.88M | 1.82M | 1.72M | 1.67M | 1.54M | 1.1M | 364K | 303K | 255K | 211K |
Stock-Based Compensation | 2.17M | 2.19M | 2.9M | 2.69M | 2.79M | 2.84M | 3.08M | 3.1M | 3.4M | 3.6M | 3.57M | 2.94M | 2.86M | 2.34M | 1.1M |
Other Working Capital | -5.45M | 152K | -1.67M | 201K | 1.71M | -716K | 51K | -138K | 1.75M | -1.45M | -1.41M | 14K | 1.59M | -5.91M | -467K |
Other Non-Cash Items | -1.63M | -202K | 6.55M | 2.06M | 1.88M | 33K | 1.36M | -1.26M | 513K | 433K | 1.21M | 36K | 83K | 23.88M | 11.48M |
Deferred Income Tax | n/a | n/a | n/a | -1.07M | -1.11M | 1.63M | n/a | n/a | n/a | n/a | n/a | 501K | 918K | 446K | 2.27M |
Change in Working Capital | -5.22M | -548K | -2.58M | -981K | 110K | -810K | -564K | -2.38M | -3.58M | -7.15M | -3.71M | 225K | 2.47M | -5.29M | -323K |
Operating Cash Flow | -19.79M | -18.04M | -23.7M | -18.9M | -16.81M | -20M | -17.93M | -19.92M | -21.79M | -25.55M | -19.84M | -15.7M | -10.98M | -15.84M | -9.19M |
Capital Expenditures | -7K | -1K | -25K | -392K | -110K | -306K | -162K | -1.82M | -1.13M | -2.14M | -939K | -1.77M | -1.62M | -966K | -507K |
Cash Acquisitions | n/a | n/a | n/a | 38.33M | n/a | 34.78M | -73.11M | -1.99M | 36.99M | 7.87M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -18.67M | -19.18M | -54.5M | -33.85M | -88.23M | -7.02M | -35.5M | -74.07M | -29.95M | -35.19M | -49.61M | -23.41M | -21.05M | -101.61M |
Sales Maturities Of Investments | 42.3M | 42.63M | 50.79M | 55.54M | 9.26M | 53.45M | 80.13M | 37.49M | 37.08M | 22.08M | 44.52M | 28.06M | 19.33M | 10.65M | 11.65M |
Other Investing Acitivies | n/a | n/a | n/a | -38.33M | n/a | -34.78M | 73.11M | 1.99M | -36.99M | -7.87M | 9.32M | -21.55M | -4.09M | -10.4M | -89.95M |
Investing Cash Flow | 42.29M | 23.96M | 31.58M | 651K | -24.7M | -35.09M | 72.94M | 171K | -38.12M | -10.01M | 8.39M | -23.32M | -5.71M | -11.37M | -90.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | n/a | 130.5M |
Common Stock Repurchased | 80K | n/a | n/a | -6K | n/a | -6K | -7K | -450K | 94K | -421K | -11K | n/a | -1.42M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -145K | 80K | n/a | 78K | n/a | 618K | 13K | 1.2M | 27K | 90K | 34K | -2.77M | 25K | 3.49M | n/a |
Financial Cash Flow | n/a | 80K | n/a | 72K | n/a | 618K | 6K | 750K | 27K | 101K | 23K | 810K | -1.32M | 239.15M | 133.48M |
Net Cash Flow | 23.11M | 6.01M | 7.88M | -18.18M | -41.52M | -54.47M | 55.02M | -19M | -59.88M | -35.46M | -11.43M | -38.21M | -18M | 211.95M | 33.84M |
Free Cash Flow | -19.8M | -18.04M | -23.73M | -19.29M | -16.92M | -20.3M | -18.1M | -21.73M | -22.91M | -27.69M | -20.78M | -17.47M | -12.6M | -16.81M | -9.69M |